About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Shhtm1Ahk
targeted mutation 1, Andreas H Kottmann
MGI:5440762
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Shhtm1Ahk/Shhtm1Ahk B6.Cg-Shhtm1Ahk MGI:5440835
cn2
Shhtm1Ahk/Shhtm1Ahk
Slc6a3tm1(cre)Xz/Slc6a3+
involves: 129S1/Sv * C57BL/6 MGI:5440834


Genotype
MGI:5440835
hm1
Allelic
Composition
Shhtm1Ahk/Shhtm1Ahk
Genetic
Background
B6.Cg-Shhtm1Ahk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Shhtm1Ahk mutation (0 available); any Shh mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are born alive, are fertile and have a normal life span with no signs of any overt morphological and functional phenotype




Genotype
MGI:5440834
cn2
Allelic
Composition
Shhtm1Ahk/Shhtm1Ahk
Slc6a3tm1(cre)Xz/Slc6a3+
Genetic
Background
involves: 129S1/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Shhtm1Ahk mutation (0 available); any Shh mutation (45 available)
Slc6a3tm1(cre)Xz mutation (2 available); any Slc6a3 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• at about 18 months

nervous system
• in the the substantia nigra pars compacta at 4, 8 and 16 months
• in the ventral tegmental area at 16 months
• in the striatum at 14 months
• non cell-autonomous
• in striatal TH+ fiber density at 12 months
• in ChAT+ neurons in the striatum at 6 months
• in striatal TH+ fiber density at 8 months
• impaired amphetamine elicited

behavior/neurological
• mice exhibit increased gait length coefficient of variability at 10 months of age, and shortened time allotted for braking in each stride and increased paw angle at 11 months of age compared with wild-type mice
• however, treatment with L-DOPA and THP normalizes increased variability in stride length, THP normalizes brake stride ratio and treatment with L-DOPA normalizes alterations in paw angles
• at 2 to 5 months
• at 7 to 12 months
• rapidly deteriorating locomotion activity leading to pelvic dragging followed by partial hindlimb paralysis at about 18 months

homeostasis/metabolism
• in the ventral midbrain at 16 months
• in the striatum at 2 and 16 months
• in the ventral midbrain at 2 months
• in the striatum at 7 months





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory